MarketCap
Facebook
X
TelegramCountry |
 Danmark |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
20 M |
Market Cap[1] |
$ 31.3 M |
EBITDA (LTM) |
$ 17.6 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Trean Insurance Group
TIG
|
- | - | $ 316 M | Nasdaq Global Select Market |  USA |
 |
SQZ Biotechnologies Company
SQZ
|
- | 57.95 % | $ 12.8 M | NYSE | USA |
 |
MEI Pharma
MEIP
|
- | 10.43 % | $ 20.5 M | Nasdaq Capital Market | USA |
 |
Palatin Technologies
PTN
|
- | - | $ 13 M | NYSE American | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
ММЦБ
GEMA
|
- | - | - | MOEX | Russia |
 |
Lyra Therapeutics
LYRA
|
- | - | $ 24.9 M | Nasdaq Global Market | USA |
 |
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB | Russia |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX | Russia |
 |
ОЗОН Фармацевтика
OZPH
|
- | - | - | MOEX | Russia |
 |
Промомед
PRMD
|
- | - | - | MOEX | Russia |
 |
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
ESSA Pharma
EPIX
|
- | - | $ 8.86 M | Nasdaq Capital Market |  Canada |
 |
Generation Bio Co.
GBIO
|
- | - | $ 344 M | Nasdaq Global Select Market | USA |
 |
Clearside Biomedical
CLSD
|
- | - | $ 25.3 M | Nasdaq Global Market | USA |
 |
Merus N.V.
MRUS
|
- | - | $ 5.78 B | Nasdaq Global Select Market |  Niderland |
 |
RAPT Therapeutics
RAPT
|
- | - | $ 2.36 B | Nasdaq Global Select Market | USA |
 |
Exicure
XCUR
|
$ 1.09 | 3.81 % | $ 6.86 M | Nasdaq Capital Market | USA |
 |
Cellectis S.A.
CLLS
|
$ 0.95 | -3.3 % | $ 95.3 M | Nasdaq Global Market |  France |
 |
AbCellera Biologics
ABCL
|
$ 12.03 | 1.78 % | $ 3.59 B | Nasdaq Global Select Market | Canada |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 58.93 | 1.57 % | $ 7.88 B | Nasdaq Global Select Market,SPB | USA |
 |
BioMarin Pharmaceutical
BMRN
|
$ 55.62 | -0.59 % | $ 10.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Celldex Therapeutics
CLDX
|
$ 29.48 | 0.79 % | $ 1.96 B | Nasdaq Global Select Market | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
$ 3.75 | 2.18 % | $ 45.8 M | Nasdaq Capital Market |  Israel |
 |
Jaguar Health
JAGX
|
$ 2.36 | 15.44 % | $ 5.5 M | Nasdaq Capital Market | USA |
 |
Protalix BioTherapeutics
PLX
|
$ 2.49 | -2.35 % | $ 196 M | NYSE American | Israel |
 |
uniQure N.V.
QURE
|
$ 21.65 | -3.5 % | $ 1.24 B | Nasdaq Global Select Market | Niderland |
 |
Stoke Therapeutics
STOK
|
$ 25.41 | 1.48 % | $ 1.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Xencor
XNCR
|
$ 29.2 | 15.95 % | $ 2.17 B | Nasdaq Global Select Market,SPB | USA |
 |
Annexon
ANNX
|
$ 3.71 | -1.2 % | $ 575 M | Nasdaq Global Select Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 1.71 | -4.21 % | $ 2.82 M | NYSE American | Israel |
 |
Incyte Corporation
INCY
|
$ 113.3 | -2.08 % | $ 22.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Mesoblast Limited
MESO
|
$ 12.43 | 1.22 % | $ 15 B | Nasdaq Global Select Market |  Australia |
 |
MeiraGTx Holdings plc
MGTX
|
$ 9.2 | -0.16 % | $ 740 M | Nasdaq Global Select Market | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 516.39 | -1.44 % | $ 132 B | Nasdaq Global Select Market,SPB | USA |
 |
Burford Capital Limited
BUR
|
$ 3.24 | -3.72 % | $ 710 M | NYSE |  Britain |
 |
Catalyst Biosciences
CBIO
|
$ 12.77 | -0.39 % | $ 1.14 B | Nasdaq Capital Market | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 25.47 | 1.29 % | $ 1.19 B | Nasdaq Global Select Market | USA |
 |
Anika Therapeutics
ANIK
|
$ 21.19 | -1.07 % | $ 304 M | Nasdaq Global Select Market,SPB | USA |
 |
Editas Medicine
EDIT
|
$ 2.4 | 0.05 % | $ 213 M | Nasdaq Global Select Market,SPB | USA |
 |
Evogene Ltd.
EVGN
|
$ 0.37 | 0.44 % | $ 2.91 M | Nasdaq Global Market | Israel |
 |
EyePoint Pharmaceuticals
EYPT
|
$ 0.36 | -10.09 % | $ 26.4 K | Nasdaq Global Market | USA |
 |
Fortress Biotech
FBIO
|
$ 1.87 | -3.11 % | $ 52.2 M | Nasdaq Capital Market | USA |
 |
Fennec Pharmaceuticals
FENC
|
$ 10.12 | 0.4 % | $ 289 M | Nasdaq Capital Market | USA |
 |
Foghorn Therapeutics
FHTX
|
$ 2.04 | 2.0 % | $ 128 M | Nasdaq Global Market | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
$ 13.76 | 4.13 % | $ 11.5 B | NYSE |  India |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 9.91 | 0.71 % | $ 271 M | Nasdaq Global Market,SPB | Israel |
 |
Sanofi
SNY
|
$ 41.77 | 0.41 % | $ 51 B | Nasdaq Global Select Market | France |
 |
Arcutis Biotherapeutics
ARQT
|
$ 31.74 | 1.73 % | $ 4.04 B | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.